The Efficacy Evaluation of CHOLESWISE Pressed Candy on Cardiovascular Health

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-09

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the efficacy evaluation of CHOLESWISE Pressed Candy on cardiovascular disease risk factors

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers

NCT01541826

Cardiovascular Disease Oxidative Stress

COMPLETED NA

Acute Cardio-metabolic Responses to Montmorency Tart Cherry Supplementation in Metabolic Syndrome Patients

NCT03615885

Metabolic Syndrome Insulin Resistance Hypertension

COMPLETED NA

The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function

NCT04021342

Cardiometabolic Risk Factors Cognitive Function Exercise Capacity

COMPLETED NA

Effects of Cocoa Products on Cardiovascular Disease Risk Factors

NCT00511420

Cardiovascular Diseases

COMPLETED PHASE3

Acute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals

NCT04960527

Uric Acid Cardiovascular Diseases Gout

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single center, randomized, double-blind and placebo controlled study. Subjects are informed to consume the samples every day for 8 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo pressed candy

Group Type PLACEBO_COMPARATOR

Placebo pressed candy

Intervention Type DIETARY_SUPPLEMENT

consume 2 tablets per day for 8 weeks

CHOLESWISE pressed candy

Group Type EXPERIMENTAL

CHOLESWISE pressed candy

Intervention Type DIETARY_SUPPLEMENT

consume 2 tablets per day for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo pressed candy

consume 2 tablets per day for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

CHOLESWISE pressed candy

consume 2 tablets per day for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Natto combined Phyllanthus emblica pressed candy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 30 years old, no gender limit;
* Patients with high blood pressure (systolic blood pressure\> 120 mmHg or diastolic blood pressure\> 80 mmHg) or high blood lipids (TC ≥ 5.18 mmol/L or TG ≥ 1.7 mmol/L), and no medication is used;
* Fully understand the purpose, benefits, potential risks and side effects of this research, and can objectively cooperate with doctors to complete the examination and assessment of diseases and physical conditions;
* People who voluntarily agree and sign an informed consent form.

Exclusion Criteria

* People with a history of dyspepsia would affect the absorption of the test product;
* Any situation that may affect trial process, including difficult-to-control organic disease or infection, unstable angina pectoris, congestive heart failure and other severe disease;
* People with symptomatic and difficult-to-control neurological, mental diseases or mental disorders;
* Pregnant or breast-feeding women or women who have a positive result on a pregnancy test;
* Allergic to the components of the test product;
* Take supplementary foods and health supplements with the same efficacy two weeks before and during the test.

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes